Turnstone Biologics Corp.
SEC CIK 1764974 · TSBX · last insider filing 2025-08-12
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Orbimed Advisors LLC | Director | filed 2023 - 2025 |
| Orbimed Capital GP VI LLC | Director | filed 2023 - 2025 |
| Gupta Rishi | Director | filed 2023 - 2025 |
| Jerel Davis | Director | filed 2023 - 2025 |
| Waddill William D. | Director | filed 2024 - 2024 |
| Gould Robert J | Director | filed 2023 - 2024 |
| Rajangam Kanya | Director | filed 2023 - 2024 |
| Burgess Michael F. | Director · Interim Chief Medical Officer | filed 2023 - 2023 |
| Farah Sammy J. | Director · President & CEO | filed 2023 - 2023 |
| Machado Patrick | Director | filed 2023 - 2023 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Abbot Stewart | Chief Scientific Officer | filed 2023 - 2023 |
| Campisi Peter Joseph Jr. | Chief Legal Officer | filed 2023 - 2023 |
| Ramanan Venkat | Chief Financial Officer | filed 2023 - 2023 |
| Azmat Saryah | Chief Business Officer | filed 2023 - 2023 |
| Chiruvolu Vijay | Int. Chief Technology Officer | filed 2023 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.